Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

GAPO syndrome causes growth issues, hair loss, missing teeth, and vision problems.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

BTA safely and effectively treats hair loss, and works better with FNS.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Increasing XIAP and DDRGK1 can help prevent hearing loss from loud noise.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Compound 4 is a promising treatment for hair loss with low toxicity.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The assay quickly identifies substances that increase or decrease blood vessel growth.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Blocking LFA-1 prevents hair loss in mice.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.